Foxo Technologies Inc
FOXO0.092USD
0.0000.00%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
31.56K시가총액
손실P/E TTM
자세한 내용은 Foxo Technologies Inc 회사
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Foxo Technologies Inc 정보
종목 코드 FOXO
회사 이름Foxo Technologies Inc
상장일Dec 11, 2020
CEOMr. Seamus Lagan
직원 수- -
유형Ordinary Share
회계 연도 종료Dec 11
주소477 South Rosemary Avenue
도시WEST PALM BEACH
증권 거래소US 'Other OTC' and Grey Market
국가United States of America
우편 번호33401
전화16128000059
웹사이트http://delwinds.com/
종목 코드 FOXO
상장일Dec 11, 2020
CEOMr. Seamus Lagan
Foxo Technologies Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.60%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Fri, Jan 23
마지막 업데이트: Fri, Jan 23
주주
주주 유형
주주
주주
비율
Sabby Management, LLC
9.99%
기타
90.01%
주주
주주
비율
Sabby Management, LLC
9.99%
기타
90.01%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
9.99%
기타
90.01%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
30
249.32M
14.24%
+249.19M
2025Q3
34
103.47K
0.13%
+57.49K
2025Q2
43
122.62K
2.30%
-40.72K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Sabby Management, LLC
--
0%
-4.05K
-100.00%
Mar 31, 2025
Rennova Health, Inc.
51.44K
0%
--
--
Dec 16, 2025
Kr8 ai Inc
11.91K
0%
--
--
Dec 16, 2025
Corbin Capital Partners, L.P.
1.38K
0%
--
--
Dec 31, 2024
Susquehanna International Group, LLP
--
0%
-1.37K
-100.00%
Mar 31, 2025
Tower Research Capital LLC
--
0%
-105.00
-100.00%
Jun 30, 2025
Geode Capital Management, L.L.C.
--
0%
-6.42K
-100.00%
Sep 30, 2025
Barnes (Bret)
168.00
0%
--
--
Dec 16, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
날짜
배당락일
유형
비율
Nov 15, 2024
Merger
0→0
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
Oct 30, 2023
Merger
10→1
